The Aenova Group has entered an agreement to acquire Haupt Pharma, which specializes in contract development and manufacturing for the pharmaceutical industry. Financial details were not disclosed. The transaction, subject customary closing conditions, is expected to be finalized at end of 2013.   Both companies have global footprints with European foundations and headquarters in Germany. The merger expands Aenova’s range of products and services with its existing production network increasing f...